Dual Use Research of Concern Boston University and Boston Medical Center.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

THE NIH RECOMBINANT DNA 2002 GUIDELINES East Carolina University September 5, 2007.
The Fellowships aim to: Educate scientists and engineers on the intricacies of federal policymaking Provide scientific and technical knowledge to support.
Moving Forward with Safety Management Systems December 9, 2014 Standing Committee on Public Transportation Winter Meeting American Association of State.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.
Lessons Learned in Initiating and Conducting Risk Assessments within a Risk Analysis Framework: A FDA/CFSAN Approach Robert Buchanan DHHS Food and Drug.
Brian J. Gorman, M.Sc., J.D. Towson University, Maryland Presentation for The National Academies’ Committee on Scientific Communication and National Security.
Control and response measures Dr. Christina Rundi Ministry of Health, Malaysia Foodborne Outbreak Investigation, Hanoi, 1-5 June 2009.
DUAL USE RESEARCH OF CONCERN US Government (USG) Policy for Institutional Oversight of Life Sciences 10/13/2014.
1 The Basic Problem: Dual-Use Research Kathryn Nixdorff Department of Microbiology and Genetics Darmstadt University of Technology, Germany.
Health Aspect of Disaster Risk Assessment Dr AA Abubakar Department of Community Medicine Ahmadu Bello University Zaria Nigeria.
Addressing Synthetic Biology and Biosecurity
Regulation and Safety Assessment of Novel Foods in Canada William Yan, Ph.D. Office of Food Biotechnology Health Canada.
Dual-Use: The Fink Report
Draft Lecture No 14 By Malcolm Dando. I. Outline The concept of dual-use Slides The Fink Committee Report –A. Objective and structure of the report.
The Growth of Dual-Use Bioethics Lecture No.13 Further Inf. For further information and video link please click on the right buttons in the following slides.
Produce Safety Rule Phase 2 Workgroup 1.
UK Office for Security & Counter Terrorism Future threats and the potential role of the CBRN Action plan in supporting the BTWC Dr Catherine Terry International.
Enhancing the Climate Resilience of Africa’s Infrastructure ACPC Role.
The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE SCIENCES Anthony Atkin (Research Impact.
LIMITLESS POTENTIAL | LIMITLESS OPPORTUNITIES | LIMITLESS IMPACT Copyright University of Reading IMPACT AND THE LIFE SCIENCES Anthony Atkin (Research Impact.
AFI Comprehensive Implementation Programme (ACIP), in cooperation with AFCAC and other stakeholders, to organize Pan African Training Coordination Conferences.
Service System for Management and Sharing of Scientific Data in Medicine Depei Liu, Ph.D. Chinese Academy of Medical Sciences.
RS–IAP-ICSU, September 2006 NSABB National Science Advisory Board on Biosecurity Dual Use Research: Scope, Criteria and Communication.
Translating Knowledge to On-the-Ground Results Henry L. Green, Hon. AIA National Institute of Building Sciences Congressional.
Dr. Anna Palmisano, Deputy Administrator, Competitive Programs The Cooperative State Research, Education and Extension Service Competitive Programs.
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA ACPS Subcommittee on Manufacturing Science: Identification and Prioritization.
KENTUCKY YOUTH FIRST Grant Period August July
Risk Assessment. Risk As defined by Kaplan and Garrick, risk analysis consists of answering three specific questions: what can happen? what is the chance.
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 6 Enforce Laws and Regulations that Protect Health and Ensure.
The AIACC Project Assessments of Impacts and Adaptations to Climate Change in Multiple Regions & Sectors UNFCCC Workshop Bonn 9 June 2003.
The African CDM Training Workshop and Preparatory UNFCCC COP9 Meeting Addis Ababa, Ethiopia, October 20 – 21, 2003 INSTITUTIONAL SET-UP FOR CDM Dr Youba.
Module N° 8 – SSP implementation plan. SSP – A structured approach Module 2 Basic safety management concepts Module 2 Basic safety management concepts.
Pathogen Reduction Dialogue Panel 4 May 7, 2002 On Farm Food Safety A Process of Intervention Martin Firth Manager, Policy and Strategies Canadian Food.
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
Excellence in science The Royal Society is the independent scientific academy of the UK dedicated to promoting excellence in science. Royal Society’s work.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
The New Role and New Mission of Cooperative Auditing Department in Thailand. Assist. Prof. Dr. Ratana Pothisuwan Assoc. Prof. Dr. Prasert Janyasupab Department.
1 18 March 2010AGNA meeting EASAC update Yves Morier.
ESPON 2013 Programme Info Day on New Calls and Partner Café Call for Proposals on Applied Research.
Advisory Committee for Diversity in the Digital Age.
Mid – Late 1970’s Emergence of recombinant DNA technology Concerns among both scientific community and general public:  Public health and safety  Environmental.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and.
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
Technology Needs Assessments under GEF Enabling Activities “Top Ups” UNFCCC/UNDP Expert Meeting on Methodologies for Technology Needs Assessments
ECDC role in public health crisis --- ECDC public health event operation plan Preparedness and response unit Improved co-ordination and support to response.
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
The MESICIC Experience & Civil Society Participation.
"When does new science become a threat?".. problem - experimentation - discovery The scientific process.
1 The Argument for Oversight: Developments in the US John Steinbruner University of Maryland Controlling Dangerous Pathogens Project: Regional Workshop.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Christine Yalda, J.D., Ph.D. Chair, Human Research Review Committee Grand Valley State University.
ISO Session 3 Environmental Management and Ethics in Management.
EIAScreening6(Gajaseni, 2007)1 II. Scoping. EIAScreening6(Gajaseni, 2007)2 Scoping Definition: is a process of interaction between the interested public,
New Ecological Science Advice for Ecosystem Protection The EPA Science Advisory Board (SAB) Staff Office supports three external scientific advisory committees.
Dual Use Research of Concern
Stanford University Dual Use Research of Concern in the Life Sciences
Impact and the Physical Sciences
Multi-purpose center for adult education in clean environment
TRAINING POLICY FOR AVIATION SAFETY IN AFRICA
Robert Jimmy Aquaculture Adviser
Health Technology Assessment in India
Presentation transcript:

Dual Use Research of Concern Boston University and Boston Medical Center

Scope of Presentation The goal of this presentation is to provide a general awareness on the dual use dilemma as it relates to academic research. The specific aims are to provide: A brief h istorical and regulatory perspective leading up to the formulation of Dual Use Research of Concern (DURC). The National Science Advisory Board for Biosecurity (NSABB) proposed framework. Familiarity to the DURC criteria. Understanding the initial steps that BU/BMC have taken to address the issue of Dual Use. The Principal Investigator’s role.

Changing Regulatory Climate The United States Government recognized that information gained from life sciences research could potentially be misused in a way that could threaten public health and safety, agricultural crops and other plants, animals, the environment, or materiel. It therefore charged the National Science Advisory Board for Biosecurity (NSABB) to develop a framework for the oversight of “Dual Use Research of Concern” (DURC).

National Science Advisory Board for Biosecurity (NSABB) 2004 NSABB The National Science Advisory Board for Biosecurity (NSABB) has been charged to develop guidelines for the oversight of “Dual Use Research of Concern” (DURC)

Dual Use Research of Concern (DURC) Definition of DURC* “Research that, based on current understanding, can be reasonably anticipated to provide knowledge, products, or technologies that could be directly misapplied by others to pose a threat to public health and safety, agricultural crops and other plants, animals, the environment, or materiel”. * Source: National Science Advisory Board for Biosecurity (NSABB)

Dual Use Biosecurity Dilemma Example: Re-construction of 1918 flu virus published papers (Tumpey 2005 and Taubenberger 2005). Risk: Information may be misused by others to construct similar deadly pathogens for bio- weapon. Other Example: Aerosolized drug delivery Engineered large porous micro carriers (“whiffle balls”) deliver more drugs into the lung. Risk: Information may allow others to use the technology/approach for delivery aerosolized bio-weapons.

Regulatory Outcome The Federal Government is expected to establish guidelines, based on NSABB recommendations, that will require research institutions to govern the execution and public communication of DURC. * Strongly promote the free and open exchange of information.

BU/BMC Advisory Committee on DURC In July 2009, BU-BMC Advisory Committee on DURC issued its report with the following key recommendations to be implemented in two phases: Phase I Conduct awareness education and training for BU/BMC. Set up an interim review and decision process for DURC related research. Phase II Develop and implement an institutional policy. Implementation of policy and maintenance.

BU/BMC Advisory Committee on DURC Possible Outcome of Reviews Allow research to continue unfettered Modify research so it is no longer a DURC Allow the study to continue with constraints Do not allow the research to move forward

Experiments Identified by NSABB NSABB identified seven categories that meets DURC: Enhances the harmful consequences of a biological agent or toxin. Disrupts the immunity or the effectiveness of an immunization without clinical and/or agricultural justification. Confers to a biological agent or toxin, resistance to clinically and/or agriculturally useful prophylactic or therapeutic interventions against that agent or toxin or facilitate their ability to evade detection methodologies. Increases the stability, transmissibility, or the ability to disseminate a biological agent or toxin. Alters the host range or tropism of a biological agent or toxin. Enhances the susceptibility of a host population. Generates a novel pathogenic agent or toxin or reconstitute an eradicated or extinct biological agent. * Already part of screening process of research by the IBC.

Assessment and Evaluation Initial assessment of research by Principal Investigator for Dual Use Scientific Review by Federal Advisory Panel or Private Sector Consultant Institutional Action by OGC, Administration, Others Technical Safety Committee Review by IBC / LSC EHS

Next Steps The federal government has not adopted recommendations by NSABB. Additional guidelines will be developed for institutions to follow. Although the regulation is not in place, the institution will begin to address the dilemma in the event that such research takes place. The institution will determine the entity that will be in charge to help govern and address the dilemma. The Institution will need to work with you to seek advise and recommendations in order to implement the recommendations by the Ad-hoc committee on DURC.